Research Report University Hospital of the clinical trial 1200.55

Abstract

An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)

Keywords

• Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
• Afatinib